March 31st, 2021
Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials
The two fast-growing organizations will combine innovative software platform and proven recruitment tactics to optimize the efficiency of patient recruitment campaigns
BOSTON, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s marketplace are delivered directly into Reify Health’s StudyTeam™, offering a common platform for sites and sponsors to manage pre-screening, enrollment, and reporting for clinical trials.
During clinical trials, sites are faced with burdensome tasks that impede the work of patient care. Once a research site’s database has been exhausted for patient referrals, additional recruiting relies on multiple sources, such as site- and sponsor-driven campaigns. Traditionally, sites then manually keep track of complicated referral feeds across studies and sources, creating a bottleneck in the enrollment funnel. Sites spend extensive time and effort updating various online environments to untangle data and manage the flow of information, instead of on high-value activities like pre-screening and patient care. Sponsors and clinical research organizations (CROs) are also forced to check multiple sources for patient updates to monitor study progress.
With this partnership, SubjectWell’s qualified referrals are delivered via Reify Health’s Recruitment Partner Interface (RPI) directly into StudyTeam, where research coordinators already handle the bulk of pre-screening and enrollment work. Sites are then empowered to update, manage, and report on the entire enrollment funnel from a single, secure, and easy-to-use platform. The combined SubjectWell and Reify Health solution, used across more than 5,000 sites globally, matches the strength of risk-free patient recruiting with a streamlined site workflow solution to create a stronger enrollment funnel that reduces burden for sites and increases randomization rates for sponsors. Several leading biopharmaceutical sponsors, including Eli Lilly and Company, are already leveraging the partnership between Reify Health and SubjectWell to improve referral workflows and accelerate enrollment for key trials across their research portfolios.
“This partnership combines our site-focused workflow solutions with SubjectWell’s high-touch and risk-free approach to finding patients for trials." — Ralph Passarella, CEO and co-founder of Reify Health
“Research sites are tasked with the lion’s share of recruitment work, but the sheer volume of potential patient sources makes it impossible to carry that work out effectively,” said Ralph Passarella, CEO and co-founder of Reify Health. “The resulting burden placed on sites makes it difficult for sponsors to understand the value of their investments in various recruitment strategies. This partnership combines our site-focused workflow solutions with SubjectWell’s high-touch and risk-free approach to finding patients for trials. We’re thrilled to be partnering with the innovative and high-energy team at SubjectWell to improve sites’ experience and increase end-to-end visibility into the ROI of recruitment strategies.”
“We see sites as critical partners in the recruitment process and are excited to partner with Reify Health and their best-in-class technology, to help ease site burdens,” added Ivor Clarke, CEO of SubjectWell. “The benefits that come from consolidating all referrals onto a single, easy-to-use platform are powerful for both the sites and sponsors. We’re committed to StudyTeam as the new standard in enrollment performance management.”
About Reify Health
Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify serves the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies. The global healthcare system relies on clinical trials to develop new, life-saving treatments for patients. Reify Health’s StudyTeam software empowers both the research sponsors who drive clinical trials forward and the doctors and research coordinators who care for patient volunteers so that they can devote more focus and time toward the work that results in successful clinical research. To learn more, visit www.reifyhealth.com.
SubjectWell, the risk-free clinical trials marketplace for patient recruitment, is raising awareness of clinical research in the general population and providing patients more choice and easy access to innovative treatment options. Visit SubjectWell.com to find out more.
The proprietary technology delivers patient referrals directly to its ...Read More
Reify Health Powers Patient Recruitment and Enrollment Across AstraZeneca’s Extensive Breast Cancer Clinical Trial Pipeline
AstraZeneca will use Reify Health’s StudyTeam™ platform to accelerate ...Read More